UAE Antibiotics Market to grow with a CAGR of 4.37%
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Antibiotics Market.
According to TechSci Research report, “UAE
Antibiotics Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2018-2028”,
UAE Antibiotics Market has valued at USD 0.52 billion in 2022 and is
anticipated to witness an impressive growth in the forecast period with a CAGR
of 4.37% through 2028. This
can be due to collaborations and partnerships among leading companies with a
diverse approach to merge the expertise of individual companies and to
strengthen their position.
The rising prevalence of chronic
diseases and co-morbiditie indirectly contribute to an increased demand for
antibiotics. Individuals
with chronic diseases often have weakened immune systems, making them more
susceptible to bacterial infections. These infections may require antibiotic
treatment to effectively manage and prevent complications. Patients with
chronic diseases, such as diabetes or cardiovascular conditions, may develop
secondary bacterial infections because of their weakened immune status. Antibiotics
are commonly prescribed to address these bacterial complications and prevent
further health deterioration. Individuals with chronic diseases may require
long-term care, either in hospitals, nursing homes, or home care settings.
Long-term care facilities can be prone to outbreaks of bacterial infections,
necessitating the use of antibiotics for treatment and infection control.
Some chronic diseases, such as
autoimmune disorders or certain cancers, require immunosuppressive therapies to
manage symptoms. These treatments can increase the risk of infections, making
antibiotics necessary when bacterial infections occur. Individuals with chronic diseases may
undergo surgeries or medical procedures. Antibiotics are commonly used
prophylactically before surgeries to prevent postoperative infections,
particularly in patients with chronic conditions that may compromise their
immune response.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Antibiotics Market.”
In October 2018, Dr.
Reddy’s Laboratories has completed the sale of the antibiotics manufacturing
facility and associated assets in Bristol, Tennessee, which it acquired from
GlaxoSmithKline (GSK) seven years ago. The facility has been sold to Neopharma;
a company based in the United Arab Emirates. This divestiture aligns with our
strategic goal to streamline and optimize global cost structures, enabling us
to concentrate on other key business priorities for sustained growth.
Supply
chain disruptions pose a challenge to the antibiotics market in the UAE, as
they can impact the availability and distribution of pharmaceutical products,
including antibiotics. Many pharmaceutical companies have
manufacturing facilities located in different countries. Disruptions in one
region, whether due to natural disasters, geopolitical issues, or public health
emergencies, can impact the production capacity of antibiotics. Transportation
disruptions, such as delays at ports, restrictions on movement, or logistical
challenges, can affect the timely delivery of pharmaceutical products.
Antibiotics, being time-sensitive medications, may face challenges in reaching
distribution points and pharmacies. Stringent quality control and regulatory
compliance standards are essential in the pharmaceutical industry. Disruptions
that impact the ability to maintain these standards, such as changes in
regulatory requirements or supply chain interruptions, can affect the release
of antibiotics into the market. Events like pandemics or other public health
emergencies can strain supply chains globally. The COVID-19 pandemic, for
example, has highlighted vulnerabilities in supply chains and logistics,
impacting various industries, including pharmaceuticals.
UAE Antibiotics Market is
segmented based on Drug Class, Spectrum, Source, Route of Administration, Distribution
Channel, and by region.
Based on the Drug Class,
UAE Antibiotics
Market is segmented into Cephalosporin, Penicillin, Amoxicillin, Azithromycin, Clindamycin,
Tetracycline, Others. Tetracycline is a broad-spectrum antibiotic that belongs
to the class of drugs known as tetracyclines. It is used to treat a variety of
bacterial infections caused by susceptible strains of bacteria. Tetracycline
and its derivatives inhibit bacterial protein synthesis, making it effective
against a wide range of Gram-positive and Gram-negative bacteria, as well as
certain other microorganisms. Tetracycline inhibits bacterial protein synthesis
by binding it to the bacterial ribosome, preventing the attachment of
aminoacyl-tRNA to the mRNA-ribosome complex. This interference disrupts the
elongation of the peptide chain during protein synthesis, leading to the
inhibition of bacterial growth. Tetracycline has a broad spectrum of activity,
making it effective against various bacteria. It is commonly used to treat
respiratory tract infections, urinary tract infections, skin and soft tissue
infections, sexually transmitted infections, and certain other bacterial
diseases.
Based on Region, Abu Dhabi region held the largest share
in the UAE Antibiotics
Market. The accessibility of healthcare
services, including the availability of medical professionals, clinics, and
hospitals, can impact the demand for antibiotics. Regions with better access
may see higher utilization. The success of public health campaigns and
educational initiatives promoting responsible antibiotic use can influence the
market. If Abu Dhabi has been particularly effective in this regard, it may
experience better antibiotic consumption patterns. Abu Dhabi serves as a global
business hub, attracting a diverse population, it may encounter a broader range
of health challenges and subsequently have a higher demand for antibiotics.
Some of the major companies operating in
the UAE Antibiotics
Market include:
- Novartis
UAE
- Pfizer UAE
- Glenmark
Pharmaceuticals UAE
- GlaxoSmithKline
UAE
- AstraZeneca
UAE
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Antibiotics.
The growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the UAE Antibiotics
Market in the forecast period," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
UAE Antibiotics Market by Product
Type (Drug Class (Cephalosporin, Penicillin, Amoxicillin, Azithromycin,
Clindamycin, Tetracycline, Others), By Spectrum (Broad Spectrum Antibiotics,
Narrow Spectrum Antibiotics), By Source (Natural, Semisynthetic, Synthetic), By
Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital
Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Antibiotics Market and provides statistics & information on market size, structure,
and future market growth. The report intends to provide innovative market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in UAE Antibiotics Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com